跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Advagraf Prolonged Release Hard Capsules 0.5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
Advagraf Prolonged Release Hard Capsules 0.5 mg
Approved
STANDARD
Advagraf Prolonged Release Hard Capsules 0.5 mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
d5e3e7746adce55a
Company
Unknown
Type
Standard
Approval Details
Approval Id
d5e3e7746adce55a
Drug Name
Advagraf Prolonged Release Hard Capsules 0.5 mg
Active Ingredients
Tacrolimus monohydrate 0.51 mg eqv anhydrous Tacrolimus 0.5 mg
0.5 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
d5e3e7746adce55a
Type
Standard
Back to HSA Approvals
